PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
10531310-9	1999	In cells, overexpressing IGF-I receptors alone, IGF-I addition enhanced cellular proliferation, even in the presence of etoposide and MMS.	Etoposide	120-129	insulin-like growth factor 1	Mus musculus	25-30	
11884589-5	2002	PTP-1B-deficient cells exhibited enhanced IGF-I-mediated protection from apoptosis in response to serum withdrawal or etoposide killing, as well as enhanced plating efficiency and IGF-I-mediated motility.	Etoposide	118-127	insulin-like growth factor 1	Mus musculus	42-47	
10640289-5	2000	After interleukin-3 withdrawal or etoposide treatment, exogenous IGF-1 prevented apoptosis and elevated levels of Cdc2, a biochemical indicator of a functional IGF-1 receptor pathway.	Etoposide	34-43	insulin-like growth factor 1	Mus musculus	65-70	
10531310-9	1999	In cells, overexpressing IGF-I receptors alone, IGF-I addition enhanced cellular proliferation, even in the presence of etoposide and MMS.	Etoposide	120-129	insulin-like growth factor 1	Mus musculus	48-53	
7812962-0	1995	Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.	Etoposide	68-77	insulin-like growth factor 1	Mus musculus	0-28	
7812962-0	1995	Insulin-like growth factor I (IGF-I) and the IGF-I receptor prevent etoposide-induced apoptosis.	Etoposide	68-77	insulin-like growth factor 1	Mus musculus	30-35	
7812962-4	1995	The addition of IGF-I markedly inhibited etoposide-induced apoptosis in a concentration-dependent manner.	Etoposide	41-50	insulin-like growth factor 1	Mus musculus	16-21